Drug Price Transparency Bills May Be Empty Calories
Executive Summary
Price justification legislation is advancing in both chambers of Congress. But CBO scores them as no savings.
You may also be interested in...
Drug Pricing Policies Attached To Surprise Medical Billing Legislation
Strategy could improve chances of passage, offer politicians the opportunity to show the public they are doing something to address drug pricing.
Orphan Drug Makers Would Escape Price Reporting Requirements Under House Bill
Legislation pending in US House Energy and Commerce Committee would exempt drugs treating diseases with less than 200,000 patients from needing to justify price increases.
The Greatest FDA Advisory Committees Of All Time Part IV: Neurology Lays Claim To The Crown
We look back at another of the greatest FDA advisory committees of the last 20 years. This time: the nearly 12-hour meeting in 2016 on Sarepta’s eteplirsen for Duchenne muscular dystrophy.